The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1)

EDITORIAL  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):1-2

Editor’s page

Bisi G.

PDF

EDITORIAL  MIBG IN NEUROBLASTOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):3-5

Theranostic role of MIBG in neuroblastoma

Aktolun C., Castellani M. R.

PDF

REVIEWS  MIBG IN NEUROBLASTOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):6-20

Functional-metabolic imaging of neuroblastoma

Sharp S. E., Parisi M. T., Gelfand M. J., Yanik G. A., Shulkin B. L.

Abstract PDF

REVIEWS  MIBG IN NEUROBLASTOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):21-8

Comparison of [123I]MIBG and [131I]MIBG for imaging of neuroblastoma and other neural crest tumors

Liu B., Zhuang H., Servaes S.

Abstract PDF

REVIEWS  MIBG IN NEUROBLASTOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):29-39

PET/CT imaging in neuroblastoma

Piccardo A., Lopci E., Conte M., Foppiani L., Garaventa A., Cabria M., Villavecchia G., Fanti S., Cistaro A.

Abstract PDF

REVIEWS  MIBG IN NEUROBLASTOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):40-52

Contemporary approach to diagnosis and treatment of neuroblastoma

Charron M.

Abstract PDF

REVIEWS  MIBG IN NEUROBLASTOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):53-65

131I-Metaiodobenzylguanidine therapy in children with advanced neuroblastoma

Dubois S. G., Matthay K. K.

Abstract PDF

REVIEWS  MIBG IN NEUROBLASTOMA

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):66-78

Optimization of molecular radiotherapy with [131I]-meta Iodobenzylguanidine for high-risk neuroblastoma

Gaze M. N., Gains J. E., Walker C., Bomanji J. B.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):79-91

Monte Carlo-based 3-dimensional dosimetry of salivary glands in radioiodine treatment of differentiated thyroid cancer estimated using 124I PET

Hobbs R. F., Jentzen W., Bockisch A., Sgouros G.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):92-100

First clinical experience with a dedicated PET for hanging breast molecular imaging

Koolen B. B., Aukema T. S., González Martínez A. J., Vogel W. V., Caballero Ontanaya L., Vrancken Peeters M. J. T. F. D., Vroonland C. J. J., Rutgers E. J. TH., Benlloch Baviera J. M., Valdés Olmos R. A.

Abstract PDF

ORIGINAL ARTICLES  

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2013 March;57(1):101-8

Thyroid remnant ablation with 1110MBq of 131I in outpatients: measurement of effective dose to household members and establishment of safety precautions

Yoshimura M., Tsutsui H., Ikeda N., Koizumi K.

Abstract PDF